2023-509605-77-00招募中1 期
A Study to Evaluate MEDI5752 in Subjects with Advanced Solid Tumors
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 205
- 试验地点
- 20
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Clinical Trial Enquiries
Scientific
AstraZeneca AB
研究点 (20)
Loading locations...
相似试验
进行中（未招募）
不适用
Treatment of Adults with Advanced, Untreated, Non-Small Cell Lung Cancer With Either MEDI-575 or MEDI-575 Plus Carboplatin and PaclitaxelPreviously untreated advanced non-small cell lung cancer in adultsMedDRA version: 14.1Level: PTClassification code 10029522Term: Non-small cell lung cancer stage IVSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: PTClassification code 10029521Term: Non-small cell lung cancer stage IIIBSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2010-023854-35-HUMedImmune, LLC112
进行中（未招募）
不适用
Treatment of Adults with Advanced, Untreated, Non-Small Cell Lung Cancer With Either MEDI-575 or MEDI-575 Plus Carboplatin and PaclitaxelEUCTR2010-023854-35-DEMedImmune, LLC112
进行中（未招募）
不适用
Treatment of Adults with Advanced, Untreated, Non-Small Cell Lung Cancer With Either MEDI-575 or MEDI-575 Plus Carboplatin and PaclitaxelEUCTR2010-023854-35-BGMedImmune, LLC112
进行中（未招募）
1 期
A Phase 2, Multicenter, Randomized, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)Relapsed or refractory diffuse large B-cell lymphoma(DLBCL)MedDRA version: 18.1Level: SOCClassification code 10029104Term: Neoplasms benign, malignant and unspecified (incl cysts and polyps)System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 18.1Level: PTClassification code 10012818Term: Diffuse large B-cell lymphomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2011-002565-38-DEMedImmune, LLC180
进行中（未招募）
不适用
A Phase 2 Randomized Open-label Study of MEDI-551 in AdultsWith Relapsed or Refractory DLBCRelapsed or Refractory Diffuse Large B-cell Lymphoma .(DLBCL)MedDRA version: 14.1Level: PTClassification code 10012818Term: Diffuse large B-cell lymphomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2011-002565-38-ITMEDIMMUNE ONCOLOGY INC170